Bausch Health Companies (TSE:BHC) Shares Up 0.3% – Time to Buy?

Shares of Bausch Health Companies Inc. (TSE:BHC) shot up 0.3% during trading on Thursday . The company traded as high as C$7.34 and last traded at C$7.20. 247,672 shares were traded during trading, a decline of 47% from the average session volume of 465,746 shares. The stock had previously closed at C$7.18.

Bausch Health Companies Stock Down 1.5%

The company has a quick ratio of 0.58, a current ratio of 1.32 and a debt-to-equity ratio of -1,009.96. The company has a market capitalization of C$2.65 billion, a PE ratio of -2.19, a price-to-earnings-growth ratio of 0.21 and a beta of 0.94. The business’s 50 day simple moving average is C$7.54 and its 200 day simple moving average is C$8.25.

Bausch Health Companies (TSE:BHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported C$1.08 EPS for the quarter. Bausch Health Companies had a negative net margin of 13.54% and a positive return on equity of 120.43%. The company had revenue of C$3.51 billion during the quarter. As a group, analysts forecast that Bausch Health Companies Inc. will post 5.5472637 EPS for the current year.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.